Singapore · Investor

ClavystBio

Last cheque observed Jul 2025. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firm

Series ASeries BProteinDrugLife Sciences Tools

Cheques on record
0%of best year0cheques in 12 months, 3 on record
Since the last cheque482days00hrs00min00sec
Median round$58MRounds led2 of 3
Pitch ClavystBio

ClavystBio highlights

  1. 01

    3 rounds on record

  2. 02

    Mostly Series A and Series D: 100% of its rounds

  3. 03

    Led 2 rounds

What they do

ClavystBio is a life sciences investor and venture builder.From their own website
Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
Series ASeries B
Sectors
ProteinDrugLife Sciences Tools
Based in
Singapore, Singapore
Cold pitches
Not stated

The record

Every round we can evidence, newest first3 appearances

  1. 2025

    3 rounds

  2. Jul
    RespireeSeries A · We Venture Capital$12MWith 6 others
  3. Jun
    Allay TherapeuticsSeries D · US · Firms' own news pages$58MLed
  4. Jan
    Leyden LabsNL · Silicon Canals$70MLed

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 16 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Recently backed

The latest companies ClavystBio put money into.

Respiree$12M · Jul 2025Allay Therapeutics$58M · Jun 2025Leyden Labs$70M · Jan 2025

Quick answers about ClavystBio

What does ClavystBio invest in?

ClavystBio invests most often at Series A and Series D (100% of the rounds on record), in sectors such as Protein, Drug and Life Sciences Tools.

How active is ClavystBio?

3 investments on record, 0 of them in the last 12 months, and it led 2. The most recent was in Jul 2025.

What has ClavystBio invested in recently?

Its most recent investments on record: Respiree (Series A, Jul 2025), Allay Therapeutics (Series D, Jun 2025) and Leyden Labs (Jan 2025).

How big are ClavystBio's cheques?

The median round it joins is $58M.

Is ClavystBio investing now?

No investments in the last 12 months; the latest was in Jul 2025.

What kind of investor is ClavystBio?

ClavystBio is a VC firm based in Singapore, Singapore.

Where does this information on ClavystBio come from?

From 3 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it